Asia-Pacific specialist CRO Novotech has signed a Memorandum of Understanding (MoU) with the China Medical University Ho...
Singapore- Artelo Biosciences, a biopharmaceutical company focused on the development of therapeutic treatments that mod...
Singapore – VistaGen Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commer...
GE Healthcare will provide China-based Xiangxue Pharmaceutical (XPH) with a FlexFactory for cell therapy. The system, ex...
Oncologie, an innovative biopharmaceutical company, recently announced that it is launching operations in both Boston an...
Singapore- TESARO, an oncology-focused biopharmaceutical company, announced that it has entered into a clinical co...
Singapore- Exact Sciences and Mayo Clinic researchers announce progress in developing a panel of blood-based D...
Singapore- Versartis and Aravive Biologics jointly announced that they have entered into a definitive agreement under wh...
Singapore- Acasti Pharma, a biopharmaceutical innovator focused on the research, development and commercialization of it...
CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorder...
Xynomic Pharma, a clinical stage US-China oncology drug development company, recently announced that it has complete...
Canada's NEOMED-LABS, a global leader in the clinical immunology field, announced a 3-year extension of t...
Singapore- Five Prime Therapeutics, a clinical-stage biotechnology company focused on discovering and developing innovat...
Singapore- Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagn...
Singapore – Repair and regeneration capacity of skeletal tissues diminishes with age, often leading to delaye...
Singapore- U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare...
Singapore- The U.S. Food and Drug Administration is warning consumers that over-the-counter (OTC) teething products cont...
People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in ...
